Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ALCON RESEARCH, LTD.

Home Clinical Trial Sponsors and OrganizationsALCON RESEARCH, LTD.

ALCON RESEARCH, LTD.

9965 Buffalo Speedway, Houston, Texas, United States

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

115

111 active

Approvals

5

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

30

26.1%

Not Applicable

5

4.3%

Unknown

1

0.9%

Trial Status Distribution

Active, not recruiting

108

93.9%

Completed

2

1.7%

Not yet recruiting

3

2.6%

Clinical Trials

Trials sponsored by this organization (115)

Assessing the usefulness of Systane COMPLETE eye drops in reducing dry eye problems

Not yet recruiting

Mar 2024105 participants

A TWO-YEAR, RANDOMIZED, DOUBLE MASKED, MULTICENTER, THREE- ARM STUDY COMPARING THE EFFICACY AND SAFETY OF RTH258 VERSUS AFLIBERCEPT IN SUBJECTS WITH NEOVASCULAR AGE RELATED MACULAR GENERATIO

Not yet recruiting

A study to investigate the combined effect of Simbrinza with other eye medication on Glaucoma

Active, not recruiting

Oct 2015280 participants

A study to investigate the combined effect of Simbrinza with other eye medication on Glaucoma

Active, not recruiting

Sep 2015188 participants

A study to investigate the combined effect of Simbrinza with other eye medication on Glaucoma

Active, not recruiting

Aug 2015188 participants

A study to investigate the combined effect of Simbrinza with other eye medication on Glaucoma

Active, not recruiting

Jul 2015280 participants

A study to investigate the combined effect of Simbrinza with other eye medication on Glaucoma

Active, not recruiting

Jul 2015280 participants

Evaluation of results in patients treated with Ocriplasmin for specific eye diseases associated with reduced visio

Active, not recruiting

Jun 2015400 participants

Page 1 of 15

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

5

Approvals

Recent Approvals

20 February 2024

Sodium Chloride + Potassium Chloride + Calcium Chloride + Magnesium Chloride

News

No news articles found

On this page

Overview
Clinical Trials115
Approvals5
News

Back to Organizations